Irritable bowel syndrome: a review of the general aspects and the potential role of vitamin D

References

• Quigley EM. Prebiotics for irritable bowel syndrome. Expert Rev Gastroenterol Hepatol. 2009 Oct;3(5):487–492. doi: 10.1586/egh.09.46.
   PubMedGoogle Scholar
• Jang A, Hwang SK, Padhye NS, et al. Effects of cognitive behavior therapy on heart rate variability in young females with constipation-predominant Irritable Bowel Syndrome: a parallel-group trial. J Neurogastroenterol Motil. 2017;23(3):435–445.
   PubMed Web of Science ®Google Scholar
• Oświęcimska J, Szymlak A, Roczniak W, et al. New insights into the pathogenesis and treatment of irritable bowel syndrome. Adv Med Sci. 2017;62(1):17–30.
   PubMed Web of Science ®Google Scholar
• Barbalho SM, Goulart RA, Gasparini RG. Associations between inflammatory bowel diseases and vitamin D. Crit Rev Food Sci Nutr. 2017;1–10. DOI:10.1080/10408398.2017.1406333
   PubMed Web of Science ®Google Scholar
• Mearin F, Lacy BE, Chang L. The Rome IV committees. In: Drossman DA, Chang LC, Kellow J W, et al., editors. Rome IV functional gastrointestinal disorders – disorders of gut-brain interaction. Vol. II. Raleigh, NC: The Rome Foundation; 2016. p. 967–1057.
   Google Scholar
• McCullough R, McCullough J. Deciphering the pathophysiology of irritable bowel syndrome and functional gastrointestinal disorders-an alternative model for pathogenesis: cytokine controlled transepithelial multi-feedback loop. Transl Gastroenterol Hepatol. 2017;17:2–18.
   Google Scholar
• Zhuang X, Tian Z, Li L, et al. Fecal microbiota alterations associated with diarrhea-predominant Irritable Bowel Syndrome. Front Microbiol. 2018;9:1600.
   PubMed Web of Science ®Google Scholar
• Menees S, Chey W. The gut microbiome and irritable bowel syndrome. F1000Res. 2018 Jul 9;7:F1000.
   PubMedGoogle Scholar
• Keating GM. Eluxadoline: a review in diarrhoea-predominant Irritable Bowel Syndrome. Drugs. 2017;77(9):1009–1016.
   PubMed Web of Science ®Google Scholar
• Barbalho SM, Goulart RA, Aranão ALC, et al. Inflammatory bowel diseases and fermentable oligosaccharides, disaccharides, monosaccharides, and polyols: an overview. J Med Food. 2018 Jul;21(7):633–640. .
   PubMed Web of Science ®Google Scholar
• Cozma-Petruţ A, Loghin F, Miere D, et al. Diet in irritable bowel syndrome: what to recommend, not what to forbid to patients! World. J Gastroenterol. 2017;23(21):3771–3783.
   Web of Science ®Google Scholar
• Cashman KD, Ritz C, Kiely M, Odin Collaborators. Improved dietary guidelines for vitamin D: application of Individual Participant Data (IPD)-level meta-regression analyses. Nutrients. 2017;9:469. .
   PubMed Web of Science ®Google Scholar
• Maalmi H, Walter V, Jansen L, et al. Association between blood 25-hydroxyvitamin D levels and survival in colorectal cancer patients: an updated systematic review and meta-analysis. Nutrients. 2018 Jul 13;10(7):E896.
   PubMed Web of Science ®Google Scholar
• Akkawi I, Zmerly H. Osteoporosis: current concepts. Joints. 2018 Jun 14;6(2):122–127.
   PubMedGoogle Scholar
• Gupta S, Mahajan VK, Yadav RS, et al. Evaluation of serum vitamin D levels in patients with systemic sclerosis and healthy controls: results of a pilot study. Indian Dermatol Online J. 2018 Jul-Aug;9(4):250–255.
   PubMedGoogle Scholar
• Schmulson MJ, Drossman DA. What is new in Rome IV. J Neurogastroenterol Motil. 2017;23(2):151–163.
   PubMed Web of Science ®Google Scholar
• Sperber AD, Dumitrascu D, Fukudo S. The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies: a Rome foundation working team literature review. Gut. 2017 Jun;66(6):1075–1082. .
   PubMed Web of Science ®Google Scholar
• Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology. 2016;150:1393–1407. doi: 10.1053/j.gastro.2016.02.031
   Web of Science ®Google Scholar
• Fukui H, Oshima T, Tanaka Y, et al. Effect of probiotic bifidobacterium bifidum G9-1 on the relationship between gut microbiota profile and stress sensitivity in maternally separated rats. Sci Rep. 2018 Aug 17;8(1):12384. .
   PubMed Web of Science ®Google Scholar
• Khodadoostan M, Shavakhi A, Sherafat Z, et al. Effect of probiotic administration immediately and 1 month after colonoscopy in diarrhea-predominant Irritable Bowel Syndrome patients. Adv Biomed Res. 2018;7:94. .
   PubMedGoogle Scholar
• Foxx-Orenstein AE. New and emerging therapies for the treatment of irritable bowel syndrome: an update for gastroenterologists. Therap Adv Gastroenterol. 2016;9(3):354–375.
   PubMed Web of Science ®Google Scholar
• Dionne J, Ford AC, Yuan Y, et al. A systematic review and meta-analysis evaluating the efficacy of a gluten-free diet and a low FODMAPs diet in treating symptoms of Irritable Bowel Syndrome. Am J Gastroenterol. 2018 Jul 26. DOI:10.1038/s41395-018-0195-4.
   PubMed Web of Science ®Google Scholar
• Montiel-Castro AJ, González-Cervantes RM, Bravo-Ruiseco, G., et al. The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality. Front Integr Neurosci. 2013;7:70.
   PubMedGoogle Scholar
• Downs IA, Aroniadis OC, Kelly L, et al. Postinfection Irritable Bowel Syndrome: the links between gastroenteritis, inflammation, the microbiome, and functional disease. J Clin Gastroenterol. 2017;51(10):869–877.
   PubMed Web of Science ®Google Scholar
• Moloney RD, Johnson AC, O’Mahony SM, et al. Stress and the microbiota-gut-brain axis in visceral pain: relevance to irritable bowel syndrome. CNS Neurosci Ther. 2016;22(2):102–117.
   PubMed Web of Science ®Google Scholar
• Sun J, Wu X, Meng Y. Electro-acupuncture decreases 5-HT, CGRP and increases NPY in the brain-gut axis in two rat models of diarrhea-predominant irritable bowel syndrome(D-IBS). BMC Complement Altern Med. 2015;15:340.
   PubMed Web of Science ®Google Scholar
• Holtmann G, Ford AC, Talley NJ. Pathophysiology of irritable bowel syndrome. Lancet Gastroenterol Hepatol. 2016;1(2):133–146.
   PubMed Web of Science ®Google Scholar
• Sainsbury A, Sanders DS, Ford AC. Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis. Clin Gastroenterol Hepatol. 2013;11(4):359–365.
   PubMed Web of Science ®Google Scholar
• Bashashati M, Rezaei N, Shafieyoun A, et al. Cytokine imbalance in irritable bowel syndrome: a systematic review and meta-analysis. Neurogastroenterol Motil. 2014;26(7):1036–1048.
   PubMed Web of Science ®Google Scholar
• Akiho H, Ihara E, Nakamura K. Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome. World J Gastrointest Pathophysiol. 2010;1(3):97–105.
   PubMedGoogle Scholar
• Vicario M, Gonzalez-Castro AM, Martinez C, et al. Increased humoralimmunity in the jejunum of diarrhoea-predominant irritable bowelsyndrome associated with clinical manifestations. Gut. 2015;64(9):1379–1388.
   PubMed Web of Science ®Google Scholar
• Zhen Y, Chu C, Zhou S, et al. Imbalance of tumor necrosis factor-α, interleukin-8 and interleukin-10 production evokes barrier dysfunction, severe abdominal symptoms and psychological disorders in patients with irritable bowel syndrome-associated diarrhea. Mol Med Rep. 2015;12(4):5239–5245.
   PubMed Web of Science ®Google Scholar
• Shulman RJ, Jarrett ME, Cain KC, et al. Associations among gut permeability, infl ammatory markers, and symptoms in patients with irritable bowel syndrome. J Gastroenterol. 2014;49(11):1467–1476.
   PubMed Web of Science ®Google Scholar
• Turcotte JF, Kao D, Mah SJ, et al. Breaks in the wall: increased gaps in the intestinal epithelium of irritable bowel syndrome patients identified by confocal laser endomicroscopy (with videos). Gastrointest Endosc. 2013;77(4):624–630.
   PubMed Web of Science ®Google Scholar
• Salvioli B, Pellegatta G, Malacarne M, et al. Autonomic nervous system dysregulation in irritable bowel syndrome. Neurogastroenterol Motil. 2015;27(3):423–430.
   PubMed Web of Science ®Google Scholar
• Tornblom H, Van O, Sadik R, et al. Colonic transit time and IBS symptoms: what’s the link? Am J Gastroenterol. 2012;107:754–760.
   PubMed Web of Science ®Google Scholar
• Barbara G, Feinle-Bisset C, Ghoshal UC, et al. The intestinal microenvironment and functional gastrointestinal disorders. Gastroenterology. 2016;150(6):1305–1318.
   Web of Science ®Google Scholar
• Talley NJ, Holtmann G, Walker MM. Therapeutic strategies for functional dyspepsia and irritable bowel syndrome based on pathophysiology. J Gastroenterol. 2015;50(6):601–613.
   PubMed Web of Science ®Google Scholar
• Bennet SP, Polster A, Törnblom H, et al. Global cytokine profies and association with clinical characteristics in patientes with Irritable Bowel Syndrome. Am J Gastroenterol. 2016;7:1–12.
   Google Scholar
• Barbáchano A, Fernández-Barral A, Ferrer-Mayorga G, et al. The endocrine vitamin D system in the gut. Mol Cell Endocrinol. 2016. DOI:10.1016/j.mce.2016.11.028.
   PubMed Web of Science ®Google Scholar
• Mai S, Walker GE, Vietti R, et al. Acute vitamin D₃ supplementation in severe obesity: evaluation of multimeric adiponectin. Nutrients. 2017;9:5.
   Web of Science ®Google Scholar
• Christakos S, Dhawan P, Verstuyf A, et al. Vitamin D: metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 2016;96(1):365–408.
   PubMed Web of Science ®Google Scholar
• Dimitrov V, White JH. Vitamin D signaling in intestinal innate immunity and homeostasis. Mol Cell Endocrinol. 2017;453:68–78.
   PubMed Web of Science ®Google Scholar
• Mohammed AH, Mirshafiey A, Vahedi H, et al. Immunoregulation of inflammatory and inhibitory cytokines by vitamin D3 in patients with inflammatory bowel diseases (IBD). Scand J Immunol. 2017;85(6):386–394.
   PubMed Web of Science ®Google Scholar
• Ooi JH, Li Y, Rogers CJ, et al. Vitamin D regulates the gut microbiome and protects mice from dextran sodium sulfate-induced colitis. J Nutr. 2013;143(10):1679–1686.
   PubMed Web of Science ®Google Scholar
• Guo C, Sinnott B, Niu B, et al. Synergistic induction of human cathelicidin antimicrobial peptide gene expression by vitamin D and stilbenoids. Mol Nutr Food Res. 2014;58(3):528–536.
   PubMed Web of Science ®Google Scholar
• Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. PNAS. 2013;110(22):9066–9071.
   PubMed Web of Science ®Google Scholar
• Luthold RV, Fernandes GR, Franco-de-Moraes AC, et al. Gut microbiota interactions with the immunomodulatory role of vitamin D in normal individuals. Metabolism. 2017;69:76–86.
   PubMed Web of Science ®Google Scholar
• Fabisiak N, Fabisiak A, Watala C, et al. Fat-soluble vitamin deficiencies and inflammatory bowel disease: systematic review and meta-analysis. J Clin Gastroenterol. 2017;51(10):878–889.
   PubMed Web of Science ®Google Scholar
• Chen J, Bruce D, Cantorna MT. Vitamin D receptor expression controls proliferation of na¨ıve CD8+ T cells and development of CD8 mediated gastrointestinal inflammation. BMC Immunol. 2014;15(6):1–11.
   PubMed Web of Science ®Google Scholar
• Aly MG, Opelz G, Daniel V. Vitamin D and Th17 lymphocytes. Transplantation. 2017;4(3–44):3–10.
   Google Scholar
• Han JE, Alvarez JA, Jones JL, et al. Impact of high-dose vitamin D3 on plasma free 25-hydroxyvitamin D concentrations and antimicrobial peptides in critically ill mechanically ventilated adults. Nutrition. 2017;38:102–108.
   PubMed Web of Science ®Google Scholar
• Berridge MJ. Vitamin D and depression: cellular and regulatory mechanisms. Pharmacol Rev. 2017;69(2):80–92.
   PubMed Web of Science ®Google Scholar
• Jhee JH, Kim H, Park S, et al. Vitamin D deficiency is significantly associated with depression in patients with chronic kidney disease. PLoS One. 2017. DOI:10.1371/journal.pone.0171009.
   PubMed Web of Science ®Google Scholar
• Zhang X, Tang Y, Maletic-Savatic M, et al. Altered neuronal spontaneous activity correlates with glutamate concentration in medial prefrontal cortex of major depressed females: an fMRI-MRS study. J Affect Disord. 2016;201:153–161.
   PubMed Web of Science ®Google Scholar
• Zator ZA, Cantu SM, Konijeti GG. Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-alpha therapy in inflammatory bowel diseases. J Parenter Enteral Nutr. 2014;38(3):385–391.
   PubMed Web of Science ®Google Scholar
• Swardfager W, Rosenblat JD, Benlamri M, et al. Mapping inflammation onto mood: inflammatory mediators of anhedonia. Neurosci Biobehav Rev. 2016;64:148–166.
   PubMed Web of Science ®Google Scholar
• Lardner AL. Vitamin D and hippocampal development-the story so far. Front Mol Neurosci. 2015;8:1–7.
   PubMed Web of Science ®Google Scholar
• Popova NK, IIchibaeva TV, Naumenko VS. Neurotrophic factors (BDNF and GDNF) and the serotonergic system of the brain. Biochemistry. 2017;82(3):308–317.
   PubMed Web of Science ®Google Scholar
• Hoang MT, Defina LF, Willis BL, et al. Association between low serum 25-hydroxyvitamin D and depression in a large sample of healthy adults: the Cooper Center longitudinal study. Mayo Clin Proc. 2011;86(11):1050–1055.
   PubMed Web of Science ®Google Scholar
• Chung H-K, Cho Y, Choi S, et al. The association between serum 25-hydroxyvitamin D concentrations and depressive symptoms in Korean adults: findings from the fifth Korea national health and nutrition examination survey 2010. PLoS One. 2014. DOI:10.1371/journal.pone.0099185.
   Web of Science ®Google Scholar
• Ishikawa C, Li H, Ogura R, et al. Effects of gravity changes on gene expression of BDNF and serotonin receptors in the mouse brain. PLoS One. 2017;12:16.
   Web of Science ®Google Scholar
• Bičíková M, Dušková M, Vítků J, et al. Vitamin D in anxiety and affective disorders. Physiol Res. 2015;64(Suppl. 2):S101–103.
   PubMed Web of Science ®Google Scholar
• Black LJ, Jacoby P, Allen KL, et al. Low vitamin D levels are associated with symptoms of depression in young adult males. Aust N Z J Psychiatry. 2014;48(5):464–471.
   PubMed Web of Science ®Google Scholar
• Sprake EF, Grant VA, Corfe BM. Vitamin D3 as a novel treatment for irritable bowel syndrome: single case leads to critical analysis of patient-centred data. BMJ Case Rep. 2012. DOI:10.1136/bcr-2012-007223
   PubMedGoogle Scholar
• Khayyat Y, Attar S. Vitamin D deficiency in patients with Irritable Bowel Syndrome: does it exist? Oman Med J. 2015;30(2):115–118.
   PubMedGoogle Scholar
• Tazzyman S, Richards N, Trueman AR, et al. Vitamin D associates with improved quality of life in participants with irritable bowel syndrome: outcomes from a pilot trial. BMJ Gastroenterol. 2015;2:e000052. .
   Google Scholar
• Jalili M, Hekmatdoost A, Vahedi H, et al. Co administration of soy isoflavones and vitamin D in management of Irritable Bowel Disease. PLoS One. 2016;11:e0158545. .
   Web of Science ®Google Scholar
• Abbasnezhad A, Amani R, Hajiani E, et al. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial. Neurogastroenterol Motil. 2016;28(10):1533–1544. .
   PubMed Web of Science ®Google Scholar
• Nwosu BU, Maranda L, Candela N. Vitamin D status in pediatric irritable bowel syndrome. PLoS One. 2017. DOI:10.1371/journal.pone.0172183.
   Web of Science ®Google Scholar
• Khayyatzadeh SS, Vatanparast H, Avan A, et al. Serum transaminase concentrations and the presence of Irritable Bowel Syndrome are associated with serum 25-hydroxy vitamin D concentrations in adolescent girls who are overweight and obese. Ann Nutr Metab. 2017;71(3–4):234–241.
   PubMed Web of Science ®Google Scholar
• El Amrousy D, Hassan S, El Ashry H, et al. Vitamin D supplementation in adolescents with irritable bowel syndrome: is it useful? A randomized controlled trial. Saudi J Gastroenterol. 2018;24(2):109–114.
   PubMed Web of Science ®Google Scholar
• Dussik CM, Hockley M, Grozić A, et al. Gene expression profiling and assessment of vitamin D and serotonin pathway variations in patients with Irritable Bowel Syndrome. J Neurogastroenterol Motil. 2018;24(1):96–106.
   PubMed Web of Science ®Google Scholar
• Abbasnezhad A, Amani R, Hasanvand A, et al. Association of serum vitamin D concentration with clinical symptoms and quality of life in patients with Irritable Bowel Syndrome. J Am Coll Nutr. 2018 Sep 25:1–7. DOI:10.1080/07315724.2018.1510349
   PubMed Web of Science ®Google Scholar
• Amani R, Abbasnezhad A, Hajiani E, et al. Vitamin D3 induced decrease in IL-17 and malondialdehyde, and increase in IL-10 and total antioxidant capacity levels in patients with Irritable Bowel Syndrome. Iran J Immunol. 2018 Sep;15(3):186–196.
   PubMed Web of Science ®Google Scholar
• Caviezel D, Maissen S, Niess JH, et al. High prevalence of vitamin D deficiency among patients with inflammatory boweldisease. Inflamm Intest Dis. 2018 Jul;2(4):200–210.
   PubMedGoogle Scholar
• Williams CE, Williams EA, Corfe BM. Vitamin D status in irritable bowel syndrome and the impact of supplementation on symptoms: what do we know and what do we need to know? Eur J Clin Nutr. 2018;72:1358–1363.
   Web of Science ®Google Scholar
• Cantorna MT, Snyder L, Lin Y. Vitamin D and 1,25 (OH) 2D regulation of T celss. Nutrients. 2015;7(4):3011–3021.
   PubMed Web of Science ®Google Scholar
• Karaahmet F, Basar Ö, Yüksel I, et al. Letter: vitamin D supplementation and the irritable bowel syndrome. Aliment Pharmacol Ther. 2013;37(4):499.
   PubMed Web of Science ®Google Scholar
• Smith YR, Stohler CS, Nichols TE. Pronociceptive and antinociceptive effects of estradiol through endogenous opioid neurotransmission in women. J Neurosci. 2006;26(21):5777–5785.
   PubMed Web of Science ®Google Scholar